Why This Small Cap Biopharma Stock Belongs In Your Portfolio

Today, we take a look at a promising biopharma concern named Flexion Pharmaceuticals who recently garnered FDA approval

There is no art which one government sooner learns of another than that of draining money from the pockets of the people.” ― Adam Smith, The Wealth of Nations

Note: To comment on or to access this full article or to get these articles freeto your ‘in box’ as published, just hit the + Follow button in the upper right-hand corner of this site.


Fresh Conversations